Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunomodulatory Properties of Umbilical Cord Vein Mesenchymal Stromal Cells Influenced by Gestational Age and in Vitro Expansion Publisher Pubmed



Abolhasani M1, 2 ; Rezaee MA3, 4 ; Mohammadi M5 ; Ghadimi T6 ; Mohammadi M5 ; Rahmani MR2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran
  2. 2. Department of Immunology and Hematology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
  3. 3. Zoonoses Research center, Kurdistan University of Medical Sciences, Sanandaj, Iran
  4. 4. Department of Medical Laboratory Sciences, Faculty of Paramedical, Kurdistan University of Medical Sciences, Sanandaj, Iran
  5. 5. Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Surgery, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran

Source: Immunology Letters Published:2018


Abstract

In vivo and in vitro aging of the mesenchymal stromal cells (MSCs) can affects their properties. We investigated the immunomodulatory properties of the term and preterm human umbilical cord vein MSCs (UCV-MSCs) at the passages (P) 2 and 5. Term and preterm UCV-MSCs at P2 and 5 were co-cultured with two-way mixed lymphocyte reaction. Proliferation, IFN-γ and IL-10 protein levels, mRNA levels of the COX-2, TGF-β1, TNF-α IL-4 and FoxP3 were assessed. The term UCV-MSCs and P5 of the term and preterm UCV-MSCs had stronger inhibitory effects on cell proliferation than the preterm UCV-MSC and P2, respectively (P = 0.001). In supernatants of the co-cultures, IFN-γ was higher in the term UCV-MSC than the preterm UCV-MSC, while IL-10 was higher in the preterm UCV-MSCs than the term UCV-MSCs. Also in the co-cultures, COX-2 expression in the term UCV-MSCs and P2 was higher than the preterm UCV-MSCs and P5, respectively and TGF-β1 expression in the term UCV-MSCs was higher than preterm. Conclusively it appears that the term UCV-MSCs, and P5 of the term and preterm UCV-MSCs showed a higher immunomodulatory ability than the preterm UCV-MSCs and P2, respectively. © 2017 European Federation of Immunological Societies
Other Related Docs
10. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis, Current Stem Cell Research and Therapy (2016)
13. Menstrual Blood-Derived Stromal Stem Cells Augment Cd4+ T Cells Proliferation, Avicenna Journal of Medical Biotechnology (2018)
23. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
26. Multipotent Stem Cell and Current Application, Acta Medica Iranica (2017)
38. Overview of Mesenchymal Stem Cells, Stem Cells in Urology (2020)